All
Team
Company
Patients
Physicians
Partners
Innovation Details
Investor Info
Due Diligence Docs
Supporters
Comments
Updates
About our project
The problem we solve: Diabetes is a chronic, metabolic disease characterised by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves.
About 422 million people worldwide have diabetes and its projected to grow up to 700 million in 2045. Diabetes already became #3 cause of death in the world (In 2021, an estimated 1.6 million deaths were directly caused by diabetes).
About our solution:
AI APS is an app built with unique neural network powered algorithm. It’s developed for protection against the possible complications associated with diabetes.
The main goal of the application is to maintain glucose within the target safe range of 3.9-10 mmol/l and to avoid the occurrence of low blood glucose values (blood hypoglycemia).
Easy setup process and configuration, user-friendly interface and powerful algorithm allow to easily achieve more than 70% TiR and make life with diabetes much more better.
Progress to
date:
We are developing for solution about 2 years. We have a community of 800 hundred people. We have already developed a working prototype of our medical device
About Our Team
Creator: Alexey Dedeshko
Location: Moskva
Bio: I'm T1D person, AI APS developer and 2 daughters farther. For 2 years we develop simple solution for T1D people to manage diabetes. I achieve 90-95% Time in Range every day and it makes me happy. I dream one day every T1D person will forget about possible diabetes complications and will start to be a little bit happier.
Diabetes is a chronic, metabolic disease characterised by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. About 422 million people worldwide have diabetes and its projected to grow up to 700 million in 2045. Diabetes already became #3 cause of death in the world (In 2021, an estimated 1.6 million deaths were directly caused by diabetes). AI APS is an app built with unique neural network powered algorithm. It’s developed for protection against the possible complications associated with diabetes. The main goal of the application is to maintain glucose within the target safe range of 3.9-10 mmol / L and to avoid the occurrence of low blood glucose values (blood hypoglycemia). Easy setup process and configuration, user-friendly interface and powerful algorithm allow to easily achieve more than 70% TiR and make life with diabetes much more better.
How We Help Physicians
The main task of the application is to maintain glucose within the target safe range of 4-10 mmol/l and to avoid the occurrence of low blood glucose values (blood
hypoglycemia).
Its ease of installation and configuration, intuitive and simple interface, as well as an excellent regulation algorithm will make life easier with diabetes and will easily achieve more than 70% in the TIR*.
How We Help Partners
Some partners may have diabetes and this helps them get sick. They will be able to follow us, communicate and learn about the progress of our projects, follow ours. We also think that some of the partners will be glad that they can make other people healthier and happier.
Innovation Details
Intellectual Property Summary
We are working on getting Intellectual Property Status for Europe and America
We are preparing for the ethics committee and clinical trials. We have no FDA approval.
The link above contains preclinical trials results
Regulatory Status
Now we are preparing for clinical trials in Europe and in about a year after that (our trials will be for 6-9 months) we will be preparing for FDA approved
How we will use the funds raised
All the collected funds and grants from this program will go for: Research & Development, Manufacturing, Labour, Packiging. Fulfilling, Taxes and Fees and Multiple/Other
Thank You
About 422 million people worldwide have diabetes and its projected to grow up to 700 million in 2045. Diabetes already became #3 cause of death in the world (In 2021, an estimated 1.6 million deaths were directly caused by diabetes). Due to AI APS we can help people avoid diabetes complication and make life of people more simple
Investor Info
Market Size
Diabetes Devices Market Size to Surpass US$ 48.8 Bn by 2030
The global diabetes devices market was reached at US$ 26.7 billion in 2020 and is predicted to surpass around US$ 48.8 billion by 2030, growing at a CAGR of 6.2% from 2021 to 2030.
We have a community of about 2000 people who expect and want to use AI APS. We have signed NDA with Menarini and Ypsomed and we are communicating and discussing the future of diabetes. We are interesting in spreading our medical device and to get licenses on use of our device for medical companies
Due Diligence Docs
Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.
Help us find best new ideas to fund by telling us what you think. Your feedback goes
straight to the team behind this project in private, so tell them what you really think.
I'm T1D person, AI APS developer and 2 daughters farther. For 2 years we develop simple solution for T1D people to manage diabetes. I achieve 90-95% Time ...
Progress to
date:
